Hi, my name is Bart Kolendowski and I am a PhD candidate in the Department of Biochemistry at Western University. I currently work at the London Regional Cancer Program in Dr. Joe Torchia’s lab researching the role of the estrogen receptor in breast cancer.
The estrogen receptor is often a therapeutic target in a subset of breast cancers. My work has focused on investigating early events in estrogen signaling to better understand how therapies work and, more importantly, why they sometimes fail.
During my tenure as a Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit (TBCRU) scholarship recipient, I have discovered previously unknown mechanisms that drive estrogen-dependent breast cancer. Importantly, these discoveries have led to the identification of new targets that may prove to be of therapeutic value for patients suffering from breast cancer.
I have been invited to present this work at the Canadian Institutes of Health Research National Student Research Competition held at the University of Winnipeg as well as the prestigious Keystone Symposia on Nuclear Receptors held in Snowbird, Utah.
Earlier this year, we submitted a manuscript based on my findings to a high-impact academic journal for publication. I am happy to announce that we are currently in the process of completing revisions and anticipate that the work will be published in the upcoming months!
None of this would have been possible without the continued support of the TBCRU and the Breast Cancer Society of Canada.
Support researchers like Bart and others by considering a donation to the Breast Cancer Society of Canada. Find out how you can help fund life-saving research, visit bcsc.ca/donate